免疫治疗明星药Keytruda有望成为致命性脑转移癌的治疗选择
一项研究发现,一种已用于治疗多种癌症的药物可有效治疗癌症柔脑膜转移。
Video: Meet Dr. Brastianos and learn about brain metastases
Departments, Centers, & Programs:
Treats:
Languages:
Mass General Brigham Cancer Institute: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-724-8770
Fax: 617-724-8769
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General has two proton therapy centers and is the only hospital in New England to offer proton therapy on site.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2025-2026.
一项研究发现,一种已用于治疗多种癌症的药物可有效治疗癌症柔脑膜转移。
Researchers at the Cancer Center collaborated with international research teams to utilize the genetic information in brain tumors as a means of understanding disease progression and inform therapies.
“We have international collaborators and now have more than a thousand brain mets in our bank that we’re going to analyze,” says neuro-oncologist Priscilla K. Brastianos, MD.
The immune checkpoint inhibitor pembrolizumab showed activity against high-grade tumors of the membranes surrounding the brain and spinal column.
Immune checkpoint inhibitors caused changes to immune cells in the cerebrospinal fluid of treated patients and generated promising results in a phase II clinical trial.
A national clinical trial led by investigators at Mass General Brigham Cancer Institute has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have specific genetic mutations.

Reviews: Comments and Ratings